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IS THE END-TIDAL PARTIAL PRESSURE OF ISOFLURANE
A GOOD PREDICTOR OF ITS ARTERIAL PARTIAL
PRESSURE?
F. J. FREI, A. M. ZBINDEN, D. A. THOMSON AND H. U. RIEDER
SUMMARY
End-tidal partial pressure of isoflurane (P£
 IS0)
may be used as a measure of anaesthetic depth.
During uptake, an arterial partial pressure (Paiso)
which is considerably less than Ptlso (Palso/PE/,so
<£ 1) leads to underestimation of depth of
anaesthesia and, during elimination, PE'iS0IPaiS0
•^  1 will lead to an overestimation of anaesthetic
depth. We measured PaIS0/Pf,S0 during a 60-min
uptake period of 1 % isoflurane and Pf',so/Pa,so
during the subsequent 60-min elimination period
in 26 patients (age 13-88 yr, ASA l-lll) under-
going various surgical procedures. After 15 min
of isoflurane uptake, Palso/Ptlso of 26 patients
was mean 0.78 (SD 0.10) and this increased only
marginally at 60min (0.79 (0.09)), whereas
during elimination, Ptlso/Paiso was in the range
0.79 (0.14)-0.83 (0.11). Predictability of PaiSQ in
a given patient is hindered by the high SD of
PaisJ PtIS0 and PE'isJ PaIS0, but it may be impro ved
by taking into account age, ASA physical status
category, vital capacity, inspired minus end-tidal
isoflurane partial pressure and arterial minus
end-tidal carbon dioxide partial pressure during
uptake; and obesity, end-tidal isoflurane partial
pressure and arterial minus end-tidal carbon
dioxide partial pressure during elimination.
However, even with multiple regression analysis
(to account for the various possible variables),
clinically useful prediction of Pa,sJPttso and
in a particular patient is not possible
(residual so 0.084 and 0.113, respectively).
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The pharmacokinetics of isoflurane have been
studied in animals [1] and healthy human volun-
teers [2]. In the latter, no significant alveolar-
arterial partial pressure difference was evident.
This may be explained by the fact that the usual
changes in pulmonary gas exchange observed
after induction of anaesthesia [3,4] did not occur
in the volunteers, as they inhaled only sub-
anaesthetic concentrations of isoflurane. In
another study, in which volunteers inhaled an-
aesthetic concentrations of halothane, a significant
alveolar-arterial partial pressure difference was
found [5] and, consequently, a similar difference
should be expected for isoflurane. Such data have
been published in a study of healthy patients
under isoflurane anaesthesia [6]. However, in a
heterogeneous patient population this difference
might be larger and related to specific patient
characteristics.
The present study was performed to investigate
differences between arterial and end-tidal partial
pressures of isoflurane during uptake and elim-
ination of isoflurane in a mixed patient population
undergoing surgery. The relationship between
this difference and age, ASA physical status
category, obesity, vital capacity (VC), forced
expiratory volume in the first 1 s (FEVj), history
of smoking habits, physical examination, chest
x-ray and position of the patient on the operating
table was also investigated. In addition, isoflurane
partial pressure differences were compared with
those of carbon dioxide.
PATIENTS AND METHODS
We studied 26 patients (16 female, 10 male; aged
13-88 yr (mean 53 yr)) undergoing elective plas-
tic, orthopaedic, abdominal, or urological surgery
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of at least 3 h duration, requiring invasive arterial
pressure monitoring. All patients gave written
informed consent and the study was approved by
the local Ethics Committee.
Patients undergoing neuro- and cardiopul-
monary surgery, and those with known coronary
heart disease were excluded.
The patient's gender and any history of pro-
ductive cough, wheezing and smoking habits were
noted. Physical examination and a chest x-ray
were performed. Lung function was tested by
measuring vital capacity (VC) and forced expired
volume in the first 1 s (FEV!) using a computer
pneumotachograph (Pneumoscreen, Jaeger, elek-
tromagnetische Geratefabrik, Wiirzburg, Ger-
many). Position on the operating table was noted
(supine or lateral).
In patients younger than 60 yr, premedication
consisted of morphine 0.1 mgkg"1 and hyoscine
0.005 mg kg"1. Premedication was not given to
patients older than 60 yr. Anaesthesia was induced
with propofol 2 mg kg"1, pancuronium 0.1 mg
kg"1 and alfentanil 0.5 mg, followed by tracheal
intubation and ventilation of the lungs with
100% oxygen. Anaesthesia was maintained by a
continuous infusion of propofol 6 mg kg"1 h"1.
Clinical signs of light anaesthesia were treated
with alfentanil in bolus doses of 0.5-1.0 mg.
Ventilation of the lungs was performed using a
Siemens 900C ventilator at a rate of 6 b.p.m. and
a tidal volume of 8-12 ml kg"1 body weight to
maintain end-tidal Pco2 at 4.2-4.8 kPa. Arterial
pressure was monitored via a 20-gauge catheter in
the radial artery and recorded every 5 min. ECG,
nasopharyngeal temperature, degree of muscle
relaxation (train-of-four) and inhaled oxygen
concentration were monitored. After a minimum
of 30 min following the initial bolus of propofol,
surgery was started.
Five to 10 minutes later, isoflurane was intro-
duced into the system at a constant inspired
concentration of 1.0%. It was discontinued after
60 min and elimination was studied during the
following 60 min. Arterial blood samples were
taken for measurement of carbon dioxide and
isoflurane partial pressures 5 min before and 1, 3,
5, 10, 15, 20, 30, 45 and 60 min after the start of
isoflurane administration, and 1, 3, 5, 10, 15, 20,
30, 45 and 60 min after discontinuing isoflurane.
End-tidal carbon dioxide partial pressure
(PE'C O J) , inspired and end-tidal isoflurane partial
pressures (Piiso, Pz'iso) w e r e measured with Beck-
man LB2 analysers by aspirating gas (flow rate of
500 ml min"1 each) from the connection between
the tracheal tube and the Y-piece of the breathing
system. The instruments were calibrated before
each experiment. End-tidal partial pressures
were determined using peak detection. Data
were recorded continuously on a three-channel
recorder (YEV3056 pen recorder, Yokogawa
Hokushin Electric, Japan).
The blood samples were placed on ice, and
Paco2 was analysed within 45 min after blood
collection with an IL System 1302 blood-gas
analyser; the values were corrected for the
patient's temperature [7].
A slight modification of the method described
by Zbinden and colleagues [8] was used for
measuring the partial pressure of isoflurane in
arterial blood (Pai5O). As it was not always possible
to withdraw the exact quantity of 0.5 ml of blood
during rapid blood sampling, the weight of the
vials was determined before and after sampling to
ensure that the exact amount of blood withdrawn
was known, so that all gas chromatographic
measurements could be corrected to 0.5 ml of
blood. All measurements of isoflurane partial
pressure were made at 37 °C (Pnis0). Because
temperatures of some of the patients decreased
considerably, temperature correction of the values
was necessary. A separate study to determine the
temperature correction factor was performed.
Blood from five volunteers was tonometered
with 1 % isoflurane. Equilibration for at least
15 min was allowed at temperatures of 33, 35, 37
and 39 °C. Two blood samples of 0.5 ml each
were withdrawn from the tonometer at each
temperature, placed into a 5-ml vial and equilib-
rated with the headspace at the corresponding
temperature. Headspace samples were measured
in duplicate by gas chromatography. The co-
efficient of variation was 2.8%. The temperature
correction for isoflurane partial pressure was
shown to follow an exponential course:
Pa _1 aiso — . 1A0.0135U-37)
where Paiso is the partial pressure at the patient's
temperature, t °C. This temperature coefficient
(-3.16 per cent/°C between 37 and 36 °C) agrees
with that predicted for isoflurane in water
from values for other agents ( — 3.10 per cent/°C)
[9] or with directly measured values ( — 4.36 per
cent/°C) [10].
Definitions and data analysis
Abnormal weight was defined as more than
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120% of the ideal weight for each patient [11].
The lower limits of normal VC and FEV! were
denned as a point located 1.64 RSD ( = residual
standard deviation = standard error of the esti-
mate) below the mean value for subjects of the
same height, sex and age on the regression line
[12-14]. The history was denned as either normal
or abnormal ( = recent history of productive
cough, wheezing or smoking of more than 5
cigarettes per day). Physical examination was
denned as either normal or abnormal ( = wheez-
ing or rales). Chest x-ray was denned as either
normal or abnormal ( = definitive lung pathology
such as emphysema, atelectasis, etc.).
The ratio and the difference between PE'CC,2 and
Paco, were calculated (PE'COJ Pacc>2 and PaCO2-
PE'COO, respectively). During isoflurane uptake,
the following calculations of isoflurane partial
pressure were performed: end-tidal to inspired
(PE'ISO/PI1SO), arterial to inspired (Palso/Piiso),
inspired minus end-tidal (Piiso — PE'1SO), arterial
to end-tidal (Paiso/PE'iS0) and end-tidal minus
arterial (PE'iS0 —Pa,so). End-tidal to arterial and
arterial minus end-tidal partial pressures of iso-
flurane (PE'lso/Palso and Palso - PE'ISO, respectively)
were calculated during elimination. Palso/PE'iso,
PE'1SO-Palso3 PE'iS0/Pa1S0 and Palso-PE'1SO are
referred to as "estimates of Palso" in the text.
In order to analyse the effect of patient
characteristics on isoflurane partial pressure, it
was necessary to have only one value for the
uptake or elimination period for each patient.
Because the ratio Palso/PE'lso was constant be-
tween 20 and 60 min of uptake and between 61
and 120 min of elimination (fig. 2), the mean value
for each patient was calculated during the two
periods ((Palso/PE'lso)20.60 and (PE'lso/Palso)61_120,
respectively). The influence of age (continuous
scale data) on these two variables was studied
by linear regression. All the other patient
characteristics are expressed on an ordinal
scale, therefore analysis of variance was used to
study the effect on (Palso/PE'iso)20_60 and
(*E iso/-' a l s o ) 6 1 _ 1 2 0 .
Linear regression analysis was used first to
study the relation between the estimates of Palso
and each of the various independent variables
(PI1SO-PE'1SO during uptake, PE'15O during elim-
ination and PaCo2-PE'C0:! and PE'COJPHCOI
during both time periods). Multiple regression
analysis was then tried to improve prediction of
each estimate of Palso during uptake and elimin-
ation. All independent variables which could
contribute to a better prediction were included
and a stepwise elimination of the most insignifi-
cant variables was performed. Patient character-
istics were computed as either a continuous
variable (age) or "dummy variables" (with two
dummy variables for ASA classification, because
there are three levels of the nominal scale, and one
dummy variable for all the other patient character-
istics (normal vs abnormal and supine vs lateral))
[15]. There are 18 measurements for each patient
but only one value for a specific patient character-
istic. We solved this problem by attributing the
specific patient characteristic to each of the nine
measurements during the respective time period.
RESULTS
During isoflurane uptake a rapid increase in
^also/Pilso and PE'ISO/PI1SO was observed (fig. 1);
after 10 min, more than 80 % of the values present
at 60 min were reached. However, even after
60 min of isoflurane uptake, a significant differ-
ence between PE'1SO and Piiso, and between PE'1SO
and Pa1S0 persisted.
During elimination, both PE'1SO and Palso de-
creased rapidly and reached 20 % of Pilso at the
end of the uptake period after approximately
10 min. As expected, PE'JSO was always smaller
than Palso and there was a persistent difference
between PE'1S0 and Piiso and between Palso and
PE'1S0 after 60 min. Figure 2 shows the mean ratios
Palso/PE'lso (during uptake) and PE'ibO/Palso (dur-
ing elimination).
After 20 min of isoflurane uptake, Palso/PE'lso
reached the value of 0.78 and remained constant
during the rest of the uptake period. Throughout
elimination, the mean value of all PE'lso/Palso was
0.80, with only small deviations from this value at
each particular sampling time. However, the SD of
these ratios increased as time progressed, possibly
because of an increased error in isoflurane
measurement at very small partial pressures and,
therefore, a larger fluctuation of the PE'lso/Palso
ratio.
The heterogeneity of the patient population in
terms of age, ASA physical status category,
weight, etc., is depicted in table I.
During the uptake period there was a significant
correlation between the age of the patient and
(Palso/PE'lso)2(Mi0 (table II). The ASA physical
status category was related also to small values
of (Paiso/PE'l5O)20_40, with a significant difference
between the first and second and the first
334 BRITISH JOURNAL OF ANAESTHESIA
0.8 n
0.0
20 60
Time (min)
120
FIG. 1. Uptake and elimination of isoflurane shown as mean (SD) values of the ratios arterial to inspired
(Palso/Pllso) and end-tidal to inspired (.PE'lao/Pilso) isoflurane partial pressures of isoflurane of
26 patients.
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FIG. 2. The means (SD) of the ratios Pa^/PE',^ (during uptake, left) and PB'1SO/P^ (during elimination,
right) plotted against time. Except during the first 10 min of the uptake period, the values remain
relatively constant, although the SD values indicate considerable interindividual variation.
ISOFLURANE PARTIAL PRESSURE GRADIENTS 335
TABLE I. Patient characteristics. F = female; M = male; N = normal; A = abnormal; S = supine; L = lateral
Patient
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
Sex
F
F
F
F
M
F
F
M
M
M
F
M
F
M
F
M
F
F
M
F
F
F
F
M
M
F
Age
(yr)
23
51
60
33
72
21
83
67
13
50
69
46
31
56
53
63
79
88
32
46
80
36
26
61
52
78
ASA
II
I
II
II
II
II
II
II
I
III
II
I
I
II
II
II
II
III
I
II
II
II
I
II
II
II
% Ideal
weight
93
105
108
115
90
112
137
108
74
127
97
134
113
141
126
156
95
114
112
106
96
148
93
128
122
89
VC
N
N
N
N
A
A
A
A
A
A
A
N
N
A
N
A
A
N
N
N
A
N
N
A
N
A
FEV,
N
N
N
N
N
A
N
A
N
A
N
N
A
A
N
A
N
N
N
A
N
N
N
A
N
N
History
A
N
N
N
N
N
A
A
N
A
N
A
N
N
A
A
N
N
N
N
N
N
A
N
A
N
Physical
examination
N
N
N
N
N
N
N
N
N
A
N
A
N
N
A
A
N
A
N
N
N
N
N
N
N
N
x-Ray
N
N
N
N
N
N
N
N
N
A
N
A
N
N
A
A
N
A
N
N
N
N
N
N
N
N
Position
S
S
S
S
S
L
L
S
L
L
S
S
S
S
L
S
S
S
S
S
S
S
S
S
L
S
Surgery
Mammoplasty
Mammoplasty
Pancreatic cyst
Cholecystectomy
Hip prosthesis
Internal fixation of
pelvis
Nephrectomy
Urethral
sphincteroplasty
Abdominal
lymphadenectomy
Nephrectomy
Internal fixation of
tibia
Hip prosthesis
Mammoplasty
Hip prosthesis
Fundoplication
Hemicolectomy
Cholecystectomy
Hip prosthesis
Internal fixation of
calcaneus
Anterior resection
(rectum)
Hemicolectomy
Fundoplication
Mammoplasty
Hemicolectomy
Ureterolithotomy
Thrombectomy (iliac
artery)
TABLE II. Predictive values of patient characteristics on isoflurane partial pressure ratios (mean values during steady state). No
significant («i) differences could be found for the patient characteristics sex (M vs F), position ( 5 vs L), FEV, (N vs A), patient's
history (N vs A), physical examination (N vs A) and chest x-ray (N vs A). F = female; M = male; S = supine; L = lateral;
N = normal; A = abnormal; a. = intercept; fl = slope, RSD = Residual standard deviation; ANOVA = analysis of variance, n = 26
Patient
characteristic
Uptake Elimination
o)2
Statistical
method
Age
(continuous scale)
ASA
I
II
III
Weight
N
A
Vital capacity
N
A
a = 0.916, 0 = -0.0023 (P < 0.01)
r2 = 0.262, RSD = 0.084
0.880(0.065)H
0.766 (0.080) J P<0.01
0.696(0.143) J
fN A1
ns
0.840 (0.072)1
0.735 (0.088)J P < 0 0 0 1
N = 0.874 (0.109n
A = 0.671 (0.115)J P < 0.01
Regression
analysis
ANOVA
ANOVA
ANOVA
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TABLE III. Linear
Pi?
Uptake
Elimination
regression between each
',,„ (during elimination).
Y
PE\SO-Palso
P^lso — P& Iso
of the estimates of Pall0 and
n = 234. <x = Intercept; fl =
' / •
P
X
** iso
a
='lso 0.756
;'lso 1.003
0.12
0.742
the independent variable P/(
slope. RSD — Residual standa
P
0.143
-0.086
0.125
0.061
r2
0.042
0.278
0.127
0.056
,„-??,,„ (during
rd deviation
P
0.0017
< 0.0001
< 0.0001
< 0.0005
uptake) or
RSD
0.536
0.110
0.202
0.155
TABLE IV. Linear regression between each of the estimates of Vall0 and an independent variable X. n = 234. <x= Intercept;
0 = slope. RSD = Residual standard deviation. All possible equations with X being either PaCO2 — PE/COl or PaC0JP& COl were
computed (eight equations), but only those with the smallest RSD are shown
Uptake
Elimination
Pa Pv'
1 dco 2
 J c
 co2PaCo,-PE'COi
Pv' /Pa
0.591
0.852
1.449
-0.234
0.134
-0.025
-1.38
1.19
0.357
0.235
0.190
0.263
< 0.0001
< 0.0001
< 0.0001
< 0.0001
0.439
0.114
0.195
0.138
TABLE V. Multiple regression analysis between each of the estimates of Pall0 and two independent variables \ t and X2. n = 234
a = Intercept; /? = slope. RSD = Residual standard deviation. All possible equations with the second independent variable
either
Uptake
Elimination
Poco./P*'
Pa'
co, or Pfi-,
Y
o * *^  Isn
COn — P a C O j were computed (eight
x, x,
PZ'lso ^ C O J / ^ ' C O J
equations),
a
0.011
1.153
1.474
-0.227
but only
P,
0.181
-0.094
-1.582
0.042
those with the smallest RSD are shown
P,
0.139
-0.028
0.151
1.133
r2
0.424
0.562
0.371
0.289
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
< 0.0001
RSD
0.416
0.085
0.173
0.134
and third categories. An abnormal VC was
associated with significantly smaller values of
(Paiso/PE'lso)20.60. During elimination, only
overweight was related significantly to small
The regression equations and the RSD for each
estimate of Pa,so and for PiISO-/3E'iso during
uptake and PE',SO during elimination are shown in
table III. All equations are highly significant. The
best correlation was found between the ratio
PajS0/PE'iso and Pilso — PE'^ during uptake and
between Palso —PE'1SO and PE'1SO during elimin-
ation. However, a wide scatter was present in both
periods.
There is a significant correlation between the
estimates of Paiso and the differences and the ratio
of the partial pressure of carbon dioxide (table
IV). The correlation coefficients and the RSD were
in the same range as those shown in table III.
Multiple regression analyses show that patient
characteristics did not contribute to the overall
predictability of any of the estimates of Pa,so.
The best correlation was found using the
independent variables Pilso —PE'1S0 and PE'1SO —
PaCOz as predictors for Pals,o/PE'l9o during uptake,
and PE'iS0 and Palso/PE'CO2 as predictors for
Palso —PE'1S0 during elimination (table V). Com-
pared with single regression analysis, prediction
was improved (smaller RSD).
DISCUSSION
When administering inhalation anaesthetics, most
clinicians use clinical signs as a guide to depth of
anaesthesia [16]. The introduction of inhalation
anaesthetic gas analysers into clinical practice [17]
should enable the anaesthetist to control the
anaesthetic depth by following the end-tidal
partial pressure assuming this reflects arterial
partial pressure. If, however, the difference be-
tween arterial and end-tidal partial pressure is
large, measurement of the end-tidal partial press-
ure may lead to overestimation of the "depth of
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anaesthesia" during uptake and underestimation
during elimination of an inhalation anaesthetic.
In this study, a rapid increase in both PE'1SO and
Pais0 was found initially. There was a significant
and persistent difference between Piiso and PE'1SO,
and between PE'1SO and Palso throughout the
1-h uptake period (figs 1, 2). Elimination was
characterized by rapid decrease in Paiso and PE'iS0
during the first 10 min. Thereafter, Paiso and
PE'IS0 decreased slowly with a variable difference
between the two, the ratio PE'iS0/PaJS0 being < 1
in most instances.
It is unlikely that the differences observed are
caused by anaesthetic technique or the result of a
methodological or technical error. The baseline
anaesthesia consisted of propofol, alfentanil, pan-
curonium and ventilation of the lungs with 100%
oxygen. This regimen guarantees hypnosis [18],
analgesia and neuromuscular block, and allows
controlled uptake and elimination of isoflurane
without interference by nitrous oxide. Accurate
measurement of the partial pressure of isoflurane
in blood and alveolar air is critical. The coefficient
of variation of the gas chromatographic method
used is 4.8% [8] and it can be assumed that
weighing the vials before and after sampling
further improved accuracy.
Hypothermia causes an increase in blood solu-
bility of isoflurane [10]. Because the body tem-
perature of some of our patients decreased
considerably, the measured partial pressure was
corrected by a factor which was determined in a
separate study with five healthy volunteers. The
measured data showed a coefficient of variation
of 2.8%, which is within acceptable limits and
should not cause erroneous measurements of
partial pressure, although the influence of factors
such as age and PCV on the temperature correc-
tion factor cannot be excluded.
Alfentanil or pancuronium are assumed to be
present in blood in concentrations in the nano-
gram range, and thus unlikely to influence the
measurement of isoflurane in blood. Propofol is
dissolved in a soyabean fat emulsion and con-
tinuous administration of 6 mg kg"1 h"1 ( = fat
0.06 g kg"1 h"1) could, theoretically, increase the
solubility of isoflurane in blood. The rate of
removal of soyabean fat (Intralipid) is governed
by a first order reaction in the range 5-10 % min"1
[19]. Even at an infusion rate of up to 25 g h"1 in
a 70-kg adult, it does not exceed the elimination
limits [20], therefore a constant blood concen-
tration may be assumed in this study. The
partition coefficient was measured separately
before and after administration of propofol in
three patients, and was unchanged.
In healthy awake volunteers breathing sub-
anaesthetic concentrations of isoflurane, Paiso/
PE'1SO is close to 1 [2]. It may be expected that
anaesthesia (causing an increase in VA/Q dis-
tribution [3,4]) would lead to a decrease in
PaiS0/PE'1S0 [21]. Even young, healthy volunteers
showed a decrease in the ratio between arterial
and end-tidal partial pressures of nitrous oxide
[22] and halothane at anaesthetic concentrations
[5]. In a more recent investigation, four healthy
patients underwent anaesthesia with isoflurane
[6]; end-tidal partial pressures were consistently
greater than those for arterial blood, the difference
being related to the difference between inspired
and arterial partial pressures. Unfortunately, no
quantitative analysis is provided for this relation-
ship, but visual inspection of figure 4 of that study
suggests that there is considerable variability. It
was our objective first to quantify the variability
of the gradient between PE'1SO and Paiso and second
to investigate the usefulness and limits of different
variables (patient characteristics, difference be-
tween inspired and end-tidal partial pressures of
isoflurane and difference between PaCo2 a nd
PE'CO2) in predicting arterial partial pressure.
Not surprisingly, age correlated significantly
with (Palso/PE'iso)2(Mi0. Compared with younger
individuals, in the elderly, ventilation distribution
is less uniform and, therefore, gas exchange less
efficient [23]. Airway closure tends to occur above
FRC in older patients [24]. Patients with ab-
normally small VC have significantly smaller
(Palso/PE'lso)2(Mi0. Dueck and colleagues [25] stud-
ied patients (age > 50 yr, wide range of abnormal
pulmonary function) before induction of anaes-
thesia and found modest increases in pulmonary
VA/Q distribution with a small shunt fraction
(mean 1.3 %) before induction. After induction of
halothane anaesthesia, severe gas exchange im-
pairment occurred. This was mainly a result of
increased shunt (up to 30 % of cardiac output), an
increase in low VA/Q units (up to 47 % of cardiac
output), or an increased deadspace ventilation
( F D / F T up to 0.58), or any combination of these.
VA/Q distribution was not measured in the
present study, but we can assume similar changes
in some of our patients, which may partly explain
the small values of (Pai5O/PE'iso)20_60.
The mean (Palso/PE'iso)2(Mio of 0.88 for ASA I
patients are almost identical with values reported
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in a study of healthy patients undergoing iso-
flurane anaesthesia [6]. The significantly smaller
values in patients in higher ASA categories
probably reflect some degree of impairment of
lung function.
The reason for the significantly small values of
(•f>E'iso/^ >aiso)6i-i2o m obese patients during elim-
ination is not known. After 1 h of 1 % isoflurane
administration, the degree of saturation of the
adipose tissue is still very small and therefore does
not contribute to an increased gradient. It is
more likely that the VA/Q mismatch induced
by anaesthesia takes longer to resolve in obese
patients compared with patients of normal weight.
PI,S O-PE'1 S O (during uptake) and PE'1SO (during
elimination) correlated significantly with the
estimates of Palso (table III). However, only 4.2-
27.8 % of the dependent variable are explained by
the gradient between inspired and end-tidal
partial pressures. The RSD are high and do not
allow prediction of Palso with a clinically useful
probability.
During routine anaesthesia, the gradient be-
tween Pacc,2 and PE'COJ is often known to the
anaesthetist. Both carbon dioxide and isoflurane
have a low blood/gas solubility and cross the
alveolar—capillary membrane easily; therefore,
we postulated that estimates of Pa1S0 could be
predicted from PE'coJPaCO2 or PE'C02-PaCOi. The
relatively large RSD (table IV) suggest that VA/Q
mismatch has a different effect on gas exchange of
these two compounds. Isoflurane is an inert gas
and equilibration across the alveolar-capillary
membrane is almost instantaneous, whereas car-
bon dioxide equilibration is significantly retarded
by the nature of transport of that gas in blood (i.e.
the slope of the carbon dioxide dissociation curve
and the rate at which carbon dioxide participates
in various chemical reactions with blood) [26].
This behaviour of carbon dioxide does not
influence gas exchange in young healthy, awake
men, but may affect gas exchange in areas of high
VA/Q, where isoflurane may be fully equilibrated,
in contrast with carbon dioxide. On the other
hand, isoflurane has a much greater molecular
weight than carbon dioxide, and this causes
increased diffusion limitation in the gas phase
[27-29]. This may retard equilibration of iso-
flurane between alveoli and blood compared with
carbon dioxide.
The results in table V show a definitive
improvement in the predictability of the estimates
of Pa1S0. However, it is not certain if it is clinically
useful to predict the ratio PaiS0/PE'iS0 within a
95% range of ±0.17 (which is approximately
2RSD).
There is no doubt that PE'1SO may considerably
overestimate Pa1S0 (and, therefore, anaesthetic
depth) during isoflurane uptake. This error is
particularly likely in elderly patients, in patients
with low VC, and in patients with high PaCO2 —
PE'C02 and high Pii50 — PE'1S0 differences. During
elimination, PE',SO may overestimate Pals0 (and,
therefore, recovery), especially in obese patients
and in patients with a small Paco /PE'C O ratio.
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